Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03999983 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

Study acronym: VOTER
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 12, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Active, Not Recruiting to Recruitingv10 Show 5 more changesShow less
    • Enrollment target: 100 to 150
    • Primary completion date: Dec 2024 to Mar 2026
    • Study completion date: Dec 2025 to Dec 2026
    • Study description expanded, about 8 words
    • Site details revised at 10 of 10 sites
  2. Notable Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: Dec 2024 to Dec 2025
    v9
  3. Notable Primary completion date: May 2023 to Dec 2023
    • Study completion date: May 2024 to Dec 2024
    v8
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 10 of 10 sites
    v7
  5. Notable Primary completion date: May 2022 to May 2023
    • Study sites: 3 to 10
    • Study completion date: May 2023 to May 2024
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Notable Primary completion date: May 2021 to May 2022
    • Study sites: 1 to 3
    • Study completion date: May 2022 to May 2023
    v5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 30, 2019 to Nov 19, 2019
    v4
  3. Notable Start date: Aug 30, 2019 to Oct 30, 2019v3
  4. Notable Start date: Jul 2019 to Aug 30, 2019v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Trial Details
NCT Number NCT03999983
Lead Sponsor St. Louis University
Conditions
(from sponsor)
Vertebral Artery Stenosis
Related terms Vertebrobasilar Insufficiency
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov